Controlled human infection models in vaccine development: what’s new in 2025?
M B Laurens, A P Durbin, M Cavaleri et al
07 July 2025
Expert Roundtable
Personalized neoantigen cancer vaccines in the spotlight
J Yan, R Perales-Linares, N Cooch et al
03 July 2025
Review
Leveraging in silico tools to accelerate vaccine manufacturing: the promise of computational fluid dynamics and hybrid process models
I Meln, X Li, A Gaetano Cardillo et al
01 July 2025
Viewpoint
Patient-centric approaches to vaccine development
R Desikan, C Campa, M Fourneau et al
27 June 2025
Expert Roundtable
Building trust in vaccines: why emotions are as important as facts
Stephen Hughes
23 June 2025
Interview
Post-pandemic evolution of vaccine development and manufacturing: India and beyond
Sudeep Kumar
18 June 2025
Interview
Towards deterministic bioprocesses
Sam Reffsin
09 June 2025
Expert Insight
Overcoming CMC, manufacturing, and supply chain challenges in vaccine production: a review of efforts in the Global South, with a focus on Africa
Vishal Sonje, Valerie Chambard
06 June 2025
Expert Insight
Controlled human infection models in vaccine development: what’s new in 2025?
M B. Laurens, A P. Durbin, M Cavaleri et al
29 May 2025
Watch
Resilient and flexible biopharmaceutical supply networks: strengthening the vaccine supply chain through a manufacturing supply chain data exchange
John Dyck, Kelvin Lee
29 May 2025
Viewpoint
Enabling large-scale production of a next-generation VLP polio vaccine for a post-eradication world
Nicola Stonehouse
29 May 2025
Interview
AI-driven modular platform for peptide dendrimer lipid nanocarriers: streamlining and accelerating precision nucleic acid delivery
Tristan Henser-Brownhill, Albert Kwok
22 May 2025
Viewpoint
The role of African scientists in pandemic preparedness
E Gitau, U Alam, C Murira et al
21 May 2025
Commentary
Producing low-immunogenicity, high-stability mRNA with dsRNA reduction to <0.005% (LLOQ)
Jen Dennin
21 May 2025
FastFacts
Challenges in outbreak vaccine development in the changing political climate
A Mbanya, J Borri, C Dominicus et al
20 May 2025
Commentary
A holistic approach to pandemic preparedness: exploring the importance of integrated advice
Anja Schreijer, Tomris Cesuroglu
09 May 2025
Viewpoint
Register for Bioconjugation Insights
07 May 2025
Post
Rethinking the global vaccine funding landscape: where do we go from here?
Rebecca F Grais
01 May 2025
Viewpoint
Outsmarting immune aging: designing vaccines for older adults
Birgit Weinberger
28 April 2025
Interview
Exploring mRNA quality assessment using electrophoretic separation methods
Chateen Krueger
23 April 2025
Watch
Spotlight on RNA–LNP vaccine innovation
Amit Khandhar
17 April 2025
Foreword